Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.39
+0.03 (0.47%)
Sep 22, 2026, 10:55 AM EDT - Market open

Aura Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Selling, General & Admin
35.2923.7122.4922.6223.0923.2522.8121.8420.7119.9819.7619.7119.4118.5618.0617.2515.0212.8810.097.81
Research & Development
102.7894.9290.390.7485.679.5973.371.2569.6467.8865.2358.1153.9848.3742.2437.0632.1329.2525.1620.73
Operating Expenses
138.08118.62112.79113.36108.69102.8496.1293.0990.3587.8684.9977.8273.3966.9360.354.3147.1542.1335.2528.53
Operating Income
-138.08-118.62-112.79-113.36-108.69-102.84-96.12-93.09-90.35-87.86-84.99-77.82-73.39-66.93-60.3-54.31-47.15-42.13-35.25-28.53
Interest Expense
--------------------0
Interest & Investment Income
6.866.236.637.127.568.349.43109.739.288.597.045.553.831.860.810.330.040.010.01
Other Non Operating Income (Expenses)
0.290.10.08-0.11-0.12-0.11-0.12-0.11-0.09-0.1-0.080.26-0.060.02-0.01-0.340.05-0.06-0.010
EBT Excluding Unusual Items
-130.93-112.29-106.08-106.35-101.25-94.61-86.81-83.2-80.71-78.67-76.48-70.52-67.91-63.08-58.45-53.84-46.77-42.15-35.25-28.52
Gain (Loss) on Sale of Assets
-------0.210.210.210.21-0.32-0.32-0.31-0.32--0-0.01-0-0
Pretax Income
-130.93-112.29-106.08-106.35-101.25-94.61-86.81-82.99-80.5-78.47-76.27-70.84-68.23-63.39-58.76-53.84-46.78-42.16-35.25-28.52
Income Tax Expense
0.080.10.110.120.130.080.110.230.180.180.14---------
Net Income
-131.01-112.39-106.19-106.47-101.38-94.7-86.92-83.22-80.69-78.65-76.41-70.84-68.23-63.39-58.76-53.84-46.78-42.16-35.25-28.52
Preferred Dividends & Other Adjustments
---------------1.324.988.6110.9411.75
Net Income to Common
-131.01-112.39-106.19-106.47-101.38-94.7-86.92-83.22-80.69-78.65-76.41-70.84-68.23-63.39-58.76-55.15-51.76-50.77-46.19-40.28
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
74656056525050484543403634323027201250
Shares Outstanding (Diluted)
74656056525050484543403634323027201250
Shares Change (YoY)
42.27%29.81%21.52%15.97%14.27%17.12%25.32%32.55%32.80%32.60%32.34%36.17%74.94%159.48%480.18%6350.13%4805.12%3146.67%1305.21%-
EPS (Basic)
-1.77-1.74-1.76-1.90-1.95-1.90-1.75-1.72-1.77-1.85-1.93-1.94-1.99-1.98-1.96-2.06-2.65-4.11-8.95-97.02
EPS (Diluted)
-1.77-1.74-1.76-1.90-1.95-1.90-1.75-1.72-1.77-1.85-1.93-1.94-1.99-1.98-1.96-2.06-2.65-4.11-8.95-97.02
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-103.35-91.64-85.19-88.8-84.22-80.06-81.06-74.51-74.39-72.58-64.56-65.22-60.55-56.42-55.7-50.23-48.67-45.13-34.54-25.52
Free Cash Flow Per Share
-1.40-1.42-1.41-1.58-1.62-1.61-1.63-1.54-1.64-1.71-1.63-1.79-1.77-1.76-1.86-1.88-2.49-3.65-6.69-61.48
EBITDA
-136.99-117.51-111.66-112.21-107.51-101.63-94.89-91.84-89.06-86.59-83.7-76.53-72.14-65.68-59.12-53.23-46.15-41.23-34.42-27.71
D&A For EBITDA
1.091.111.131.151.181.211.221.261.291.271.31.291.251.251.181.0810.90.830.83
EBIT
-138.08-118.62-112.79-113.36-108.69-102.84-96.12-93.09-90.35-87.86-84.99-77.82-73.39-66.93-60.3-54.31-47.15-42.13-35.25-28.53
SEC Filings: 10-K · 10-Q